Featured News
SDRC News
More News
Breaking down diabetes: Drugs for diabetes, starting with the best — metformin
A huge assortment of 100 medications are available to treat high blood sugar in Type 2 diabetes, including two historical breakthrough drugs, insulin and metformin.
Gerald Reaven, scientist who coined ‘Syndrome X,’ dies at 89
Gerald Reaven’s decades of research at Stanford helped show that insulin resistance could lead to Type 2 diabetes and multiple other diseases.
Low-fat or low-carb? It’s a draw, study finds
Stanford researchers have found that, contrary to previous studies, insulin levels and a specific genotype pattern don’t predict weight-loss success.
Special Diabetes Program
Your voice has been heard! Join us in thanking Congress for passing a renewal of the Special Diabetes Program!
High-tech imaging could reveal mysteries of bone damage in kids with chronic disease
Mary Leonard, chair of the Department of Pediatrics at Stanford, works to understand exactly how chronic diseases hurt children’s bone health.
A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...